|
MRI News Service:
Contrast Agents p15 |
|
|
|
 |
 | | | 'AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the company has updated the product label for Feraheme(R) (ferumoxytol) Injection for Intravenous (IV) use. This update is based on the U.S. Food and Drug Administration's approval of the ...' | | Tuesday, 21 June 2011 by ir.amagpharma.com |
|
|
|
| | | 'Repligen Corporation (NASDAQ: RGEN) today announced that the Company has concluded a pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) related to its lead product candidate, RG1068 for improvement of magnetic ...' | | | Wednesday, 1 June 2011 by www.businesswire.com | |
|
|
|
| | | 'Bracco Imaging and Nycomed have signed an agreement to consolidate their long-established cooperation. By the end of 2011, Bracco Imaging will take over the part of Nycomed manufacturing facilities in Singen, close to Constanz (Baden- Württemberg), ...' | | | Monday, 16 May 2011 by www.bracco.com | |
|
|
|
| | | 'Magnetic resonance imaging (MRI) using gadolinium-based contrast agents is safe in intensive care unit (ICU) patients at high risk for kidney injury, according to the results of a small retrospective study presented in poster format at the Society for ...' | | | Monday, 18 April 2011 by www.renalandurologynews.com | |
|
|
|
| | | 'Drug delivery that precisely targets cancerous cells without exposing the healthy surrounding tissue to the medication's toxic effects may soon be a reality, thanks a new research by Professor Sylvain Martel, Director of the Nanorobotics Laboratory at ...' | | | Wednesday, 16 March 2011 by www.sify.com | |
|
|
|
| | | 'The application of MRI as a non-invasive, quantitative tool for diagnosing lumbar intervertebral disc degeneration is currently an area of active research. The objective of this study was to examine, in vitro, the efficacy of a manganese chloride ...' | | | Friday, 11 March 2011 by www.ncbi.nlm.nih.gov | |
|
|
|
| | | 'The objective of this study was to compare the blood pool agent Gadomer with a small contrast agent for the visualization of ultra-small, collateral arteries (diameter<1 mm) with high resolution steady-state MR angiography (SS-MRA) in a rabbit hind limb ...' | | | Wednesday, 26 January 2011 by www.ncbi.nlm.nih.gov | |
|
|
|
| | | 'Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced a national contract with Novation for ABLAVAR® (gadofosveset trisodium) and DEFINITY® Vial For (Perflutren Lipid Microsphere) Injectable Suspension, ...' | | | Friday, 21 January 2011 by www.businesswire.com | |
|
|
|
| | | 'The FDA's panel of outside neurology experts will meet Friday to discuss risks for a serious skin disorder presented by a new, contrast agent for MRI scans of the central nervous system. The product -- gadobutrol, made by Bayer -- is one of a class ...' | | | Thursday, 20 January 2011 by www.medpagetoday.com | |
|
|
|
| | | 'A new approach that detects breast cancer vasculature is making an appearance at the 2010 RSNA meeting. The method, called high spectral and spatial resolution, or HiSS, uses water to detect tumor blood vessels without contrast. Two papers on the ...' | | | Tuesday, 30 November 2010 by www.diagnosticimaging.com | |
|
|
|
|
|
|
|
|
| Result Pages |
|
|
|
|
|
Nothing is wrong with California that a rise in the ocean level wouldn't cure.
-
Ross MacDonald |
|
|
News
top
